CA2191612A1 - Procede pour preparer des fragments de cardiodilatine; fragments de cardiodilatine hautement purifies et produits intermediaires pour la preparation de ce procede - Google Patents

Procede pour preparer des fragments de cardiodilatine; fragments de cardiodilatine hautement purifies et produits intermediaires pour la preparation de ce procede

Info

Publication number
CA2191612A1
CA2191612A1 CA002191612A CA2191612A CA2191612A1 CA 2191612 A1 CA2191612 A1 CA 2191612A1 CA 002191612 A CA002191612 A CA 002191612A CA 2191612 A CA2191612 A CA 2191612A CA 2191612 A1 CA2191612 A1 CA 2191612A1
Authority
CA
Canada
Prior art keywords
preparation
fragments
cardiodilatin fragments
highly purified
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002191612A
Other languages
English (en)
Other versions
CA2191612C (fr
Inventor
Hansueli Immer
Wolf-Georg Forssmann
Knut Adermann
Christian Klessen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiopep Pharma GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1995/002050 external-priority patent/WO1995033769A1/fr
Publication of CA2191612A1 publication Critical patent/CA2191612A1/fr
Application granted granted Critical
Publication of CA2191612C publication Critical patent/CA2191612C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
CA002191612A 1994-06-02 1995-05-30 Procede pour preparer des fragments de cardiodilatine; fragments de cardiodilatine hautement purifies et produits intermediaires pour la preparation de ce procede Expired - Lifetime CA2191612C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4420381 1994-06-02
DEP4420381.0 1994-06-02
DE19513784.1 1995-04-10
DE19513784A DE19513784A1 (de) 1994-06-02 1995-04-10 Hochreines Urodilatin und Verfahren zu seiner Herstellung
PCT/EP1995/002050 WO1995033769A1 (fr) 1994-06-02 1995-05-30 Procede et produits intermediaires utiles pour preparer des fragments de cardiodilatine, et fragments tres purs de cardiodilatine

Publications (2)

Publication Number Publication Date
CA2191612A1 true CA2191612A1 (fr) 1995-12-14
CA2191612C CA2191612C (fr) 2007-10-23

Family

ID=6520321

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002191612A Expired - Lifetime CA2191612C (fr) 1994-06-02 1995-05-30 Procede pour preparer des fragments de cardiodilatine; fragments de cardiodilatine hautement purifies et produits intermediaires pour la preparation de ce procede

Country Status (4)

Country Link
CA (1) CA2191612C (fr)
DE (2) DE19513784A1 (fr)
TW (1) TW368505B (fr)
ZA (1) ZA954506B (fr)

Also Published As

Publication number Publication date
DE59510439D1 (de) 2002-12-05
TW368505B (en) 1999-09-01
ZA954506B (en) 1996-12-02
CA2191612C (fr) 2007-10-23
DE19513784A1 (de) 1995-12-07

Similar Documents

Publication Publication Date Title
AU2671795A (en) Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
CA2275392A1 (fr) Nouvelles preparations medicamenteuses aqueuses pour la production d'aerosols depourvus de gaz propulseur
CA2248006A1 (fr) Segments de liaison actives et leurs procedes de fabrication et de purification
CA2016521A1 (fr) Proteine de liaison de la fibronectine et sa preparation
CA2147124A1 (fr) Analogues de l'erythropoietine
AU2455295A (en) Protein or polypeptide, process for producing the same, and intermediate compound tehrefor
CA2170515A1 (fr) Sequences de nucleotide pour de nouvelles proteines de type tyrosine-phosphatase
AU1155495A (en) Process for the preparation of non-cariogenic sugars
HUT39774A (en) Process for purifying recombinant dns products, and for controlling the product's purity and the effectiveness of the purification
CA2088363A1 (fr) Methode de preparation de nucleotides
AU5265296A (en) Atp-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology
CA2058676A1 (fr) Methode pour isoler l'albumine humaine du surnageant iv, en particulier du surnageant iv-4, ou de la fraction v selon cohn, ou encore d'une fraction ou d'un surnageant analogue
EP0911393A4 (fr) Peptide, procede de production et mode d'utilisation correspondants
CA2094347A1 (fr) Methode de production d'une preparation de facteur viii
AU1322692A (en) Method for the in vitro production of protein from a dna sequence without cloning
CA2143510A1 (fr) Methode pour isoler et purifier des proteines dont la synthese depend de la vitamine k
CA2209298A1 (fr) Analogues de ligand mpl
WO1988003927A3 (fr) Inhibiteurs de la renine
SG74671A1 (en) Improved process for the hydrogenation of maleic acid to 1, 4-butanediol
CA2191612A1 (fr) Procede pour preparer des fragments de cardiodilatine; fragments de cardiodilatine hautement purifies et produits intermediaires pour la preparation de ce procede
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
CA2191407A1 (fr) Methode d'utilisation du systeme promoteur adh ii de la levure pour la production biotechnologique a haut rendement de proteines heterologues
CA2196431A1 (fr) Materiaux icam-4 et procedes
CA2157387A1 (fr) Methode et compositions pour la production de proteines osteogeniques recombinantes
AU2942495A (en) Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150601